Category: Patently BIOtech
This Independence Day, Let’s Thank the Inventors
Happy Birthday AMERICA! That’s right, this Saturday is July 4. And yes, that means what …
IP Sessions at BIO 2015: The Impact of the Inter Partes Review on (BIO)Pharma
The Intellectual Property Track at the BIO International Convention was a chance for IP thought …
FDA Acts on Biosimilars
The Biologics Price Competition and Innovation Act (BPCIA) deferred to the Food and Drug Administration …
Biosimilars at the Federal Circuit – Can the Parties Be Compelled to Dance?
In 2009, Congress passed the Biologics Price Competition and Innovation Act (“BPCIA”), which for the first …
11 Days Until BIO 2015: IP Networking and Meetup Opportunities
This year’s BIO International Convention is fast approaching, with plenty of opportunities for the best …
IP Sessions at the 2015 BIO International Convention
This year’s BIO International Convention will be host to educational sessions on the latest issues …
BIO Deputy General Counsel Testifies on Patent Reform
On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front …
BIO Chair Testifies Before Senate
BIO’s Chair and CEO of GlycoMimetics, Rachel King, testified before the Senate Committee on Small …
BIO and University Organizations offer Support of STRONG Patents Act
On March 4, 2015, Senator Chris Coons (D-DE) introduced a new bill, The STRONG Patents …
BIO IPCC Spring Conference Program Announced
BIO’s 2015 IP Counsels Committee Spring Conference & Meeting will be held April 15-17 in …